AI assistant
Sending…
XBiotech Inc. — Director's Dealing 2019
Mar 4, 2019
34229_dirs_2019-03-04_f9b3840e-6936-42af-b731-24b91a4c6488.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2018-12-24
Reporting Person: MCKENZIE W THORPE (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-24 | Common Stock | P | 24838 | $5.882 | Acquired | 27738 | Indirect |
| 2018-12-26 | Common Stock | P | 18636 | $5.0744 | Acquired | 46374 | Indirect |
| 2018-12-27 | Common Stock | P | 1364 | $4.9163 | Acquired | 47738 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3398600 | Direct |
| Common Stock | 11500 | Indirect |
| Common Stock | 100000 | Indirect |
More from XBiotech Inc.
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 29
Major Shareholding Notification
2026
Jan 23
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2025
Dec 9
Interim / Quarterly Report
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12